page_banner

Products

strontium ranelate CAS: 135459-87-9

Short Description:

Catalog Number: XD94336
Cas: 135459-87-9
Molecular Formula: C12H12N2O8SSr
Molecular Weight: 431.91
Availability: In Stock 
Price:  
Prepack:  
Bulk Pack: Request Quote

Product Detail

Product Tags

Catalog Number XD94336
Product Name strontium ranelate
CAS 135459-87-9
Molecular Formula C12H12N2O8SSr
Molecular Weight 431.91
Storage Details Ambient

 

Product Specification

Appearance White powder
Assay 99% min

 

Strontium ranelate is a medication that is primarily used in the treatment of osteoporosis, a condition characterized by decreased bone density and increased risk of fractures. It is commonly prescribed to individuals who are at high risk for fractures or have experienced fractures due to osteoporosis.The main purpose of strontium ranelate is to enhance bone formation and simultaneously inhibit bone resorption. This medication works by increasing the activity of osteoblasts, which are cells responsible for building new bone, while also inhibiting the activity of osteoclasts, which are cells that break down old bone. By promoting bone formation and reducing bone loss, strontium ranelate helps to strengthen bones and reduce the risk of fractures.Strontium ranelate is typically taken orally, usually in the form of a tablet, and is typically recommended to be taken once daily. The dosage and treatment duration may vary depending on the individual's condition and response to the medication. It is important to follow the prescribed dosage and instructions provided by the healthcare provider.In clinical trials, strontium ranelate has been shown to significantly increase bone mineral density and reduce the risk of vertebral and non-vertebral fractures in postmenopausal women with osteoporosis. It has also demonstrated effectiveness in reducing the risk of fractures in men with osteoporosis.It is important to note that strontium ranelate is not suitable for everyone. It should be used with caution in individuals with certain medical conditions, such as severe kidney problems, blood clotting disorders, or a history of heart disease. Additionally, it is important to inform the healthcare provider about any other medications being taken, as there may be potential drug interactions.Like any medication, strontium ranelate may have potential side effects. Common side effects include gastrointestinal symptoms such as diarrhea, nausea, and abdominal pain. Less common but more serious side effects may include skin reactions, blood clots, or liver problems. It is important to promptly report any unusual or severe side effects to the healthcare provider.In conclusion, strontium ranelate is a medication used in the treatment of osteoporosis. By promoting bone formation and inhibiting bone resorption, it helps strengthen bones and reduce the risk of fractures. However, it is essential to use strontium ranelate as directed by a healthcare provider, be aware of any potential side effects or contraindications, and promptly report any concerns or symptoms experienced while taking the medication.


  • Previous:
  • Next:

  • Close

    strontium ranelate CAS: 135459-87-9